Chief Development Officer

Chief Development Officer LocationUSEmployment TypeFull timeLocation TypeRemoteDepartmentClinical Operations🍊Our missionGreat science regularly stalls in the clinic, not because the science is wrong, but because the company behind it lacks the capital, infrastructure, or focus to take it all the way through. Today’s clinical-stage biopharma model is broken, and as a result promising treatments never reach patients.Our mission is to fix this: we’re building the next generation of biopharma by in-licensing clinical-stage therapeutic assets and developing them through Lindus Health’s integrated, technology-first clinical trial infrastructure. We’re a new initiative, but we’re building on a proven foundation - the same infrastructure that has delivered 82% of Lindus Health’s sponsor trials on or ahead of timeline, across 40+ completed trials across the US and Europe.We’re in-licensing 5-7 clinical-stage, typically Phase-2-ready assets, funded directly from Lindus Health’s balance sheet. We’re targeting deal close on our first assets through 2026, with first trials launching in H1 2027.About the RoleAs Chief Development Officer, you will own development strategy across the Lindus Therapeutics portfolio. We are building out a first tranche of 4 to 5 in-licensed assets, with trials starting in 2027.You report to our CEO, lead the Lindus Tx team, manage our VP Corporate Development and asset leads, and sit on the company executive committee. You are the senior development voice on every asset: you determine whether and how each can be advanced quickly and capital-efficiently to a Phase 2 proof-of-concept readout that an acquirer will pay for. You set the development strategy, design the clinical studies, define the target product profile, and drive the regulatory path behind each program.This is a hands-on builder's role. You won't run a large internal department: you'll assemble and direct a lean organization of fractional and consultant CMC, regulatory, pharmacology and clinical experts, with a development lead on each program reporting to you. Knowing how to find the right expert for each function matters as much here as the development science itself. You'll have real ownership: the call on whether an asset is developable and worth pursuing sits with you. About YouA senior clinical development leader. You have led clinical programs through Phase 1 and Phase 2 at pharma or biotech companies across more than one non-oncology therapeutic area. You've designed Phase 2 proof-of-concept studies, and you understand what it takes to generate a clean, interpretable signal in each. You've engaged with the FDA and ideally the EMA on IND strategy and early development interactions, and you know what the agencies will want to see at each stage.Experience with in-licensed and partnered assets. You have experience developing assets that originated from 3rd parties, can build a development plan based on gaps in the dataset and what a future partner or acquirer might want to see.You design around the exit. You understand what a potential acquirer needs to see in the clinical and CMC package at Phase 2 proof-of-concept, including the endpoints, the dose selection rationale and the biomarker strategy, and you build the program to get there without gold-plating it.Portfolio experience. You've led or overseen multiple programs simultaneously and are comfortable making hard prioritization calls between assets.Able to run lean in a biotech setting. You've delivered strong Phase 1 and Phase 2 data within tight constraints and you'd rather build development capability through a small core team and a network of specialists than a large internal department.A network to draw on. You can stand up regulatory, CMC, pharmacology and clinical capabilities as each asset needs them, bringing in the right people on the right terms.Comfortable with AI tools. You use them across research, planning and analysis, with a clear sense of where they help and where...